Harvard Medical School


HMS Study Suggests New Narratives for Pompeii Victims

New DNA analysis challenges existing hypotheses about the identities and relationships of victims found in Pompeii after the eruption of Mount Vesuvius in 79 C.E., per a study published in Current Biology on Nov. 7.


HMS Study Sheds Light on Link Between Heart Condition and Cancer Treatment

A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous heart condition to continue immunotherapy treatment for the first time.


Harvard Medical School Alums Donate $6 Million for AI Health Care Education

The Dunleavy Foundation, led by Harvard Medical School alum Keith R. Dunleavy, gave HMS $6 million to expand educational opportunities for leveraging artificial intelligence in health care.


Harvard Study Suggests Vitamin D Has No Effect on Cardiovascular Health

Vitamin D supplementation does not reduce the risk of cardiovascular disease, researchers reported in a September paper.


Harvard Medical School Receives Federal Warning Over Animal Welfare Violation

The U.S. Department of Agriculture issued an official warning notice that Harvard Medical School researchers violated federal animal welfare laws after the school self-reported the incident.


Harvard Professor-Led Company Says It Reconstructed Genome of Extinct Tasmanian Tiger

Colossal Laboratories and Biosciences, a company co-founded by Harvard professor George M. Church, announced last week that it had reconstructed the genome of the extinct Tasmanian tiger with more than 99.9 percent accuracy — the most complete ancient genome of its kind.


Decades-Long NHS Research Jeopardized by Funding Cuts

The Nurses’ Health Study – a 48-year long medical study run jointly by the Harvard T.H. Chan School of Public Health, Brigham and Women’s Hospital, and the Harvard Medical School – is at risk of shutting down due to a lack of funding, according to researchers involved with the project.


Brigham and Women's Hospital Researchers Find Nasal Spray Protects Against Respiratory Illnesses

Researchers found that a drug-free nasal spray protected against airborne respiratory illnesses — including Covid-19, influenza, viruses, and pneumonia — in a preclinical study published by Harvard Medical School-affiliated Brigham and Women’s Hospital on Sept. 24.


Canadian Biotech Company to Supply MDMA for McLean Hospital Clinical Trial

Toronto-based MDMA manufacturer PharmAla Biotech signed a contract to supply researchers at McLean Hospital, an HMS-affiliated psychiatric teaching hospital, with the drug for a pending clinical trial, PharmAla announced in a Oct. 2 press release.


HMS Researchers Introduce AI Tool for Drug Repurposing

Harvard Medical School associate professor Marinka Zitnik and her lab announced the development of TxGNN, an artificial intelligence model which is able to suggest new treatment applications of existing drugs using neural networks.


1-25 of 818
Older ›
Oldest »